Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
Smetana J, Berankova K, Zaoralova R, Nemec P, Greslikova H, Kupska R, Mikulasova A, Frohlich J, Sevcikova S, Zahradova L, Krejci M, Sandecka V, Almasi M, Kaisarova P, Melicharova H, Adam Z, Penka M, Jarkovsky J, Jurczyszyn A, Hajek R, Kuglik P. Smetana J, et al. Among authors: jarkovsky j. Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):123-30. doi: 10.1016/j.clml.2012.11.012. Epub 2013 Jan 4. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23291040
Molecular heterogeneity and centrosome-associated genes in multiple myeloma.
Kryukov F, Nemec P, Dementyeva E, Kubiczkova L, Ihnatova I, Budinska E, Jarkovsky J, Sevcikova S, Kuglik P, Hajek R. Kryukov F, et al. Among authors: jarkovsky j. Leuk Lymphoma. 2013 Sep;54(9):1982-8. doi: 10.3109/10428194.2013.764416. Epub 2013 Feb 18. Leuk Lymphoma. 2013. PMID: 23323949
Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia.
Kryukov F, Dementyeva E, Kubiczkova L, Jarkovsky J, Brozova L, Petrik J, Nemec P, Sevcikova S, Minarik J, Stefanikova Z, Kuglik P, Hajek R. Kryukov F, et al. Among authors: jarkovsky j. Genomics. 2013 Oct;102(4):243-9. doi: 10.1016/j.ygeno.2013.06.007. Epub 2013 Jul 3. Genomics. 2013. PMID: 23831116 Free article.
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L, Kryukov F, Slaby O, Dementyeva E, Jarkovsky J, Nekvindova J, Radova L, Greslikova H, Kuglik P, Vetesnikova E, Pour L, Adam Z, Sevcikova S, Hajek R. Kubiczkova L, et al. Among authors: jarkovsky j. Haematologica. 2014 Mar;99(3):511-8. doi: 10.3324/haematol.2013.093500. Epub 2013 Nov 15. Haematologica. 2014. PMID: 24241494 Free PMC article.
NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy?
Kuricová K, Tanhäuserová V, Pácal L, Bartáková V, Brožová L, Jarkovský J, Kaňková K. Kuricová K, et al. Among authors: jarkovsky j. Kidney Blood Press Res. 2013;38(1):92-8. doi: 10.1159/000355757. Epub 2014 Feb 26. Kidney Blood Press Res. 2013. PMID: 24603156 Free article.
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Minarik J, Pavlicek P, Pour L, Pika T, Maisnar V, Spicka I, Jarkovsky J, Krejci M, Bacovsky J, Radocha J, Straub J, Kessler P, Wrobel M, Walterova L, Sykora M, Obernauerova J, Brozova L, Gregora E, Adamova D, Gumulec J, Adam Z, Scudla V, Hajek R; Czech Myeloma Group. Minarik J, et al. Among authors: jarkovsky j. PLoS One. 2015 Apr 14;10(4):e0123866. doi: 10.1371/journal.pone.0123866. eCollection 2015. PLoS One. 2015. PMID: 25875484 Free PMC article.
358 results